- Clinical Trials
- April 2024
- 60 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €869EUR$875USD£723GBP
€1242EUR$1,250USD£1,033GBP
- Clinical Trials
- April 2024
- 120 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Report
- March 2024
- 119 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- September 2024
- 188 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2024
- 180 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- April 2024
- 180 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- April 2024
- 185 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 150 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- July 2024
- 100 Pages
Global
From €2608EUR$2,625USD£2,168GBP
€3725EUR$3,750USD£3,098GBP
- Report
- May 2024
- 170 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- March 2024
- 175 Pages
Global
From €2484EUR$2,500USD£2,065GBP
The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more